Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$60.6M |
| 2 |
CoStar Group
CSGP
|
+$57.8M |
| 3 |
Consolidated Edison
ED
|
+$52.3M |
| 4 |
Deere & Co
DE
|
+$44.5M |
| 5 |
Exelon
EXC
|
+$42.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Amazon
AMZN
|
+$366M |
| 3 |
Moderna
MRNA
|
+$123M |
| 4 |
Entergy
ETR
|
+$44.9M |
| 5 |
Linde
LIN
|
+$43.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.98% |
| 2 | Industrials | 10.54% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Financials | 9.11% |
| 5 | Healthcare | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Nautilus Biotechnolgy
NAUT
$111M
| $83K | ﹤0.01% |
+13,438
| New | +$107K |
|
1927
Neurogene
NGNE
$793M
| $82K | ﹤0.01% |
570
-323
| -36% | -$49.5K |
|
1928
Radiant Logistics
RLGT
$395M
| $82K | ﹤0.01% |
12,834
-11,906
| -48% | -$76.6K |
|
1929
Safe Bulkers
SB
$881M
| $82K | ﹤0.01% |
+15,819
| New | +$61.1K |
|
|
MGI
1930
PUT
DELISTED
MoneyGram International, Inc. New
MGI
| $80K | ﹤0.01% |
+10,000
| New | +$95.3K |
|
1931
loanDepot
LDI
$301M
| $79K | ﹤0.01% |
11,668
-2,632
| -18% | -$24.6K |
|
|
NMG
1932
Nouveau Monde Graphite
NMG
$477M
| $79K | ﹤0.01% |
14,142
-123,660
| -90% | -$812K |
|
|
PTRAW
1933
DELISTED
Proterra Inc. Warrant
PTRAW
| $79K | ﹤0.01% |
+30,000
| New | +$100K |
|
|
EMKR
1934
DELISTED
Emcore Corp
EMKR
| $78K | ﹤0.01% |
1,048
-2,850
| -73% | -$228K |
|
1935
Quad
QUAD
$528M
| $77K | ﹤0.01% |
18,065
+9,686
| +116% | +$40K |
|
1936
Atlanta Braves Holdings Series B
BATRK
$3.37B
| $74K | ﹤0.01% |
2,800
-5,000
| -64% | -$132K |
|
1937
Bionano Genomics
BNGO
$14.4M
| $72K | ﹤0.01% |
+22
| New | +$77K |
|
1938
Genworth Financial
GNW
$3.74B
| $71K | ﹤0.01% |
+18,887
| New | +$67.3K |
|
|
RESN
1939
DELISTED
Resonant Inc.
RESN
| $71K | ﹤0.01% |
29,211
-25,081
| -46% | -$69.4K |
|
1940
Cyclerion Therapeutics
CYCN
$18.4M
| $70K | ﹤0.01% |
1,135
+57
| +5% | +$3.73K |
|
|
DOYU
1941
DouYu International Holdings
DOYU
$128M
| $70K | ﹤0.01% |
+2,123
| New | +$85.6K |
|
|
SOL
1942
DELISTED
Emeren Group
SOL
| $70K | ﹤0.01% |
10,600
-12,770
| -55% | -$91.7K |
|
|
SEEL
1943
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $70K | ﹤0.01% |
8
-8
| -50% | -$68.8K |
|
1944
NextCure
NXTC
$27M
| $69K | ﹤0.01% |
856
-2,621
| -75% | -$230K |
|
|
PNNT
1945
Pennant Park Investment Corp
PNNT
$246M
| $69K | ﹤0.01% |
10,666
-1,900
| -15% | -$12.5K |
|
1946
Assembly Biosciences
ASMB
$718M
| $68K | ﹤0.01% |
1,618
-4,585
| -74% | -$192K |
|
1947
Minerva Neurosciences
NERV
$230M
| $68K | ﹤0.01% |
4,899
+98
| +2% | +$1.47K |
|
|
YARW
1948
Yarrow Bioscience
YARW
$105M
| $68K | ﹤0.01% |
54
-7
| -11% | -$13.6K |
|
|
LX
1949
LexinFintech Holdings
LX
$214M
| $67K | ﹤0.01% |
+11,362
| New | +$87.6K |
|
|
CALA
1950
DELISTED
Calithera Biosciences, Inc
CALA
| $67K | ﹤0.01% |
1,537
-2,292
| -60% | -$98.9K |
|
Similar funds
Michael Gelband's Q3 2021 Portfolio in Review
As of Q3 2021, Michael Gelband held 2,951 positions worth $7.41B, down 18% from $9.04B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Michael Gelband withdrew a net $1.27B in Q3 2021, closing 919 positions and reducing 594 holdings. Its most notable exit was Amazon, an estimated $366M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Michael Gelband opened a new position in Advanced Micro Devices worth $61M.
- Michael Gelband's largest Q3 2021 buy was Advanced Micro Devices: 592,990 shares worth $61M.
- Michael Gelband added most to CoStar Group in Q3 2021, an estimated $57.8M increase.
- Michael Gelband's biggest Q3 2021 reduction was Microsoft, cutting an estimated $483M.
- Michael Gelband fully exited Amazon in Q3 2021, selling an estimated $366M.
- Michael Gelband's ten largest holdings make up 9.8% of its $7.41B portfolio in Q3 2021.
- Michael Gelband opened 679 new positions and closed 919 in Q3 2021.
- Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.41B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.